When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KRTX - Karuna to advance lead drug into Phase 3 for psychosis in schizophrenia patients
Karuna Therapeutics Inc.
Fresh off a meeting with the FDA, Karuna Therapeutics (NASDAQ:KRTX) will advance lead candidate KarXT into Phase 3 development for the treatment of acute psychosis in patients with schizophrenia.
More news on: Karuna Therapeutics, Inc., Healthcare stocks news,